Create a free Feed Strategy account to continue reading

Elanco under investigation for alleged securities fraud

Elanco Animal Health Inc. is under investigation for securities fraud, and a class action lawsuit has been filed on behalf of investors.

fraud-investigation
oksix | Bigstock.com

Elanco Animal Health Inc. is under investigation for alleged securities fraud, and a class action lawsuit has been filed on behalf of investors.

According to a press release from shareholder rights law firm Bragar Eagel & Squire PC, a class action lawsuit was filed May 20 in the United States District Court for the Southern District of Indiana on behalf of investors that purchased Elanco securities between January 10 and May 6, 2020.

The complaint alleges that Elanco made materially false and/or misleading statements and failed to disclose material adverse facts about its business, operations, and prospects. Specifically, it says Elanco failed to disclose to investors that, after consolidating its distributors from eight to four, the company increased the amount of inventory, including companion animal products, held by each distributor; that Elanco’s distributors were not experiencing sufficient demand to sell through the inventory; that, as a result, the company’s revenue was reasonably likely to decline; that, as a result of the foregoing, Elanco would reduce its channel inventory with respect to companion animal products; and that, as a result of the foregoing, defendants’ positive statements about the company’s business, operations and prospects were materially misleading and/or lacked a reasonable basis.